<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Tsinghua_Introduction_Gene_therapy"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Tsinghua/Introduction/Gene_therapy">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Tsinghua/Introduction/Gene_therapy&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Tsinghua/Introduction/Gene_therapy&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Tsinghua/Introduction/Gene_therapy&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Tsinghua/Introduction/Gene_therapy" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Tsinghua/Introduction/Gene therapy</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2014.igem.org</H3><DIV class="container"><DIV class="sidebar1"><NAV><UL><LI><A href="https://2014.igem.org/Team:Tsinghua/Main_page">MAIN PAGE</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Introduction">INTRODUCTION</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Introduction">Overview</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Introduction/Diabetes">Diabetes Type I</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Introduction/Gene_therapy">Gene Therapy</A></LI></UL><LI><A href="https://2014.igem.org/Team:Tsinghua/Project">PROJECT</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Project">Overview</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Project/Virus">The Virus</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Project/Drug">The Drug</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Project/Microbe">The Microbe</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Project/Cocktail">The Cocktail</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Modeling">Modeling</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Parts">Parts</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Safety">SAFETY</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Notebook">NOTEBOOK</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Notebook">OVERVIEW</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Notebook/Protocol">PROTOCOL</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Notebook/Lablog">LABLOG</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Human_practice">HUMAN PRACTICE</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Human_practice">OVERVIEW</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Human_practice/Gallery">GALLERY</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Human_practice/Outreach">OUTREACH</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Human_practice/Video">VIDEO</A></LI><LI><A href="https://2014.igem.org/Team:Tsinghua/Team">TEAM</A></LI></NAV></DIV><ARTICLE class="content"><H1>Introduction: Gene Therapy</H1><SECTION><H2>Definition</H2><P><I><B>Gene therapy</B></I> is the use of <I><B>DNA as a drug</B></I> to  treat disease by delivering <I><B>therapeutic DNA</B></I> into a patient’s cells. The most common form of <I><B>gene therapy</B></I> involves using DNA that encodes a functional,  therapeutic gene to replace a <A href="http://en.wikipedia.org/wiki/Mutate" title="Mutate">mutated</A> gene. Other forms involve directly <I><B>correcting a  mutation</B></I>, or using DNA that encodes a <I><B>therapeutic protein drug</B></I> (rather than a  natural human gene) to provide treatment (“Gene therapy”, Wikipedia).<I><B>Gene therapies</B></I> can be categorized as somatic gene therapies and germline ones by target cell or virus-vectored or  non-virus-vectored by vector.</P><H2>History </H2><P>Genetic engineering techniques have invoked  people’s interest in DNA modifying for clinical use. Early in 1972, the idea of  <I><B>gene therapy</B></I> was first put forward. 
              The first <I><B>gene therapy</B></I> case is in US in  1990. Then in the 1990s there are several successful cases, though partly, but  the death in a gene therapy clinical trial in 1999 
              In 2003 a team from UCLA inserted a gene into the brain, which is a great step in <I><B>brain disease treatment</B></I>.              In 2007 the first <I><B>gene therapy operation</B></I> was performed for a patient with inherited retina disease, yielding <I><B>positive results</B></I>.
              In 2012, <A href="http://en.wikipedia.org/wiki/Glybera" title="Glybera">Glybera</A> became the first gene therapy treatment to be approved for <I><B>clinical use</B></I> in  either <A href="http://en.wikipedia.org/wiki/Europe" title="Europe">Europe</A> or  the United States after its endorsement by the European Commission.
              By now in 2014 <I><B>gene therapy</B></I> is still more of an experimental approach than a <I><B>clinical therapy</B></I>. </P><H2>Advantage and drawbacks</H2><P>The advantages of <I><B>gene therapies</B></I> are quite obvious that they can cure treat some most difficult diseases under traditional therapies and previous experiments of <I><B>gene therapies</B></I> have shown some promising cases. The discovery of AAV with specific insertion site adds to people’s expectation.
              However, there are a number of <I><B>technological problems</B></I> in front of gene therapy, including short-lived nature  of gene therapy, potential risk with viral vectors and misinsertion for cancer,  and weakness in multigene diseases, etc. Even deaths are reported in gene  therapy trials. High cost may be another drawback for the current available gene therapy. </P><H2>About AAV</H2><P>AAV, <I><B>adeno-associated virus</B></I>, is a common small virus affecting human and some other primates. It is famous for <I><B>lack of pathogenicity</B></I> and <I><B>specific integration site</B></I> in host genome, which bestows it many nominations in <I><B>gene therapy</B></I>.
              Alipogene tiparvovec is a <A href="http://en.wikipedia.org/wiki/Gene_therapy" title="Gene therapy">gene therapy</A> treatment  for <A href="http://en.wikipedia.org/wiki/Lipoprotein_lipase_deficiency" title="Lipoprotein lipase deficiency">lipoprotein lipase deficiency</A> (LPLD),  which can cause severe <A href="http://en.wikipedia.org/wiki/Pancreatitis" title="Pancreatitis">pancreatitis</A>. In July 2012, the <A href="http://en.wikipedia.org/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</A> recommended  it for approval, making it the first recommendation for a gene therapy treatment in either Europe or the United States. After the endorsement of  the <A href="http://en.wikipedia.org/wiki/European_Commission" title="European Commission">European Commission</A>, Glybera (trade name for Alipogene  tiparvovec) becomes the <I><B>first gene therapy treatment</B></I> approved for clinical use in either Europe or the US. </P><H2>Connection with our project</H2><P>In our project we make use of the AAV as the carrier of the <I><B>insulin gene</B></I>, as well as other regulatory elements, trying to eventually <I><B>recover the insulin expression</B></I> inside patients’ bodies. It is based on the previous successful trials carried out for treating LPLD (lipoprotein lipase deficiency) with Alipogene tiparvovec (an AAV-based gene therapy). </P><P> </P></SECTION></ARTICLE></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2014.igem.org/Team:Tsinghua/Introduction/Gene_therapy">http://2014.igem.org/Team:Tsinghua/Introduction/Gene_therapy</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Tsinghua/Introduction/Gene_therapy" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Tsinghua/Introduction/Gene_therapy" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Tsinghua/Introduction/Gene_therapy&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Tsinghua/Introduction/Gene_therapy&amp;oldid=368015" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2014.igem.org:Privacy_policy" title="2014.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2014.igem.org:General_disclaimer" title="2014.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>